BUSINESS

• Leqembi FY2025 Global Sales Reach 88 Billion Yen: Eisai
  May 1, 2026

• Rohto Files CMV Corneal Endotheliitis Drug in Japan
  May 1, 2026

• Mochida Files in Japan for PAH Drug Tyvaso DPI
  May 1, 2026

• Tanabe Clinches EU Approval for Parkinson’s Drug Onerji
  May 1, 2026

• 3D “Deeply Disappointed” by Toho Plan to Seek Defense Trigger Approval
  May 1, 2026

• Jardiance Tops Four Promotion Channels in March: Intage
  May 1, 2026

• Sandoz Poaches Regeneron’s Yohei Ishii as Japan Chief
  April 30, 2026

• Nipro to List Forxiga AG in June Ahead of Pricing Rule Shift
  April 30, 2026

• FDA Accepts Zipalertinib NDA for EGFR Exon 20-Mutant Lung Cancer: Taiho
  April 30, 2026

• Otsuka’s IgA Drug Voyxact Sees Strong US Uptake: EVP
  April 30, 2026

• KM Biologics, India’s Serum Institute Partner on Japanese Encephalitis Vaccine
  April 30, 2026

• Japan Drug Sales Top 11 Trillion Yen in FY2025, Keytruda Leads: Encise
  April 30, 2026

• Taiho Moves Araris’ ADC into PI for Lymphoma in US
  April 30, 2026

• Gilead Files Bictegravir Plus Lenacapavir HIV Pill in Japan
  April 30, 2026

• Astellas Tops 2 Trillion Yen in Sales, Gears Up for Post-Xtandi Growth
  April 28, 2026

• Astellas Taps Sanofi Japan Chief Iwaya as Strategy Officer
  April 28, 2026

• Teikoku, Curedisc Ink Japan Deal for Disc Herniation Drug
  April 28, 2026

• FRONTEO, Science Tokyo Roll Out AI Drug Discovery Hub
  April 28, 2026

• Kyorin to Transfer Generics Unit to Daito-Led JV
  April 28, 2026

• Guardant360 Snags Japan OK as CDx for AZ’s Camizestrant
  April 28, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »